Medical device commercialization (SME scale-up)
4 European H2020 organizations list this as part of their work.
Most active in this area
- POSITRIGO AG
Swiss medtech SME developing compact, affordable brain PET scanners for early Alzheimer's and dementia detection at clinical scale.
“The company executed a textbook SME Instrument Phase 1→Phase 2 sequence, moving from a €50k feasibility study to a €2.25M product development grant within two years.”
SMECH2 projects - PK VITALITY
French medtech SME developing K'Watch Glucose, a smartwatch for painless continuous blood sugar monitoring in diabetes patients.
“The SME Phase 2 award of EUR 2.29M indicates the company passed EU evaluators' review of their business case, market strategy, and regulatory pathway, not just technical readiness.”
SMEFR2 projects - PRISMATIC SENSORS AB
Swedish deep-tech SME developing photon counting detector systems for spectral CT medical imaging, with two EU-funded development phases completed.
“The sequential use of SME Phase 1 (EUR 50k feasibility) followed by SME Phase 2 (EUR 2.4M implementation) reflects a deliberate go-to-market scaling process.”
SMESE2 projects - MARSI BIONICS SL
Spanish medical robotics SME developing powered exoskeletons to rehabilitate people with chronic ambulatory disabilities.
“The MARSI project (SME Instrument Phase 2, EUR 1.64M) represents a full commercialization push — the most demanding EU funding track for high-growth SMEs — demonstrating capacity beyond pure R&D.”
SMEES2 projects